Comparing Medium-Term Clinical Outcomes following XEN® 45 and XEN® 63 Device Implantation.
Aitor Fernández-GarcíaYing ZhouMercedes García-AlonsoHenry D AndrangoFrancisco PoyalesNuria Garzón-JiménezPublished in: Journal of ophthalmology (2020)
POAG surgical procedures with either XEN® 45 or XEN® 63 Gel Stent implantation could be a safe and effective treatment approach.
Keyphrases